Characteristics | Number of assessable patients (%) |
---|---|
Age (years) | Â |
   Median | 52 |
   Range | 15-81 |
Sex | Â |
   Male | 45 (54.2) |
   Female | 38 (45.8) |
   Ratio, male to female | 1.2 |
Presenting Symptom 1 | Â |
   Abdominal pain | 69 (83.1) |
   Melena | 30 (36.1) |
   Nausea or vomitting | 15 (18.1) |
   Hematemesis | 6 (7.2) |
   Ileus | 1 (1.2) |
   Perforation | 0 |
B symptoms | 56 (67.5) |
Bulky Disease | 21 (25.3) |
Involvement within the stomach 2 | Â |
   Cardia | 13 (15.7) |
   Fundus | 15 (18.1) |
   Corpus | 44 (53.0) |
   Antrum | 53 (63.9) |
   Pylorus | 12 (14.5) |
   Stump | 2 (2.4) |
Histopathology | Â |
B cell subtypes | 75 (90.4) |
   Diffuse large B cell lymphoma | 57 (68.7) |
GCB subtype | 20 (20/57, 35.1) |
Non-GCB subtype | 37 (37/57, 64.9) |
Ratio, GCB to Non-GCB | 1:1.85 |
   MALT lymphoma | 14 (16.9) |
   Burkitt lymphoma | 3 (3.6) |
   Mantle cell lymphoma | 1 (1.2) |
T cell subtypes | 8 (9.6) |
   Peripheral T-cell lymphoma, unspecified | 4 (4.8) |
   Anaplastic large cell lymphoma | 3 (3.6) |
   Precursor T lymphoblastic lymphoma | 1 (1.2) |
H. pylori infection3 | 49 (49/61, 80.3) |
Laboratories at first visit | Â |
   Leucocytopenia (< 4.0 × 109/L) | 7 (8.4) |
   Neutropenia (< 2.0 × 109/L) | 8 (9.6) |
   Lymphocytopenia (< 1.0 × 109/L) | 15 (18.1) |
   Low hemoglobin (< 120 g/L) | 43 (51.8) |
   Low albumin (< 35 g/L) | 24 (28.9) |
   Increased LDH (> 245 U/L) | 40 (48.2) |
Lugano Staging | Â |
   I | 24 (28.9) |
   II1 | 5 (6.0) |
   II2 | 14 (16.9) |
   IIE | 20 (24.1) |
   IV | 20 (24.1) |